Searchable abstracts of presentations at key conferences in endocrinology

ea0040p18 | (1) | ESEBEC2016

Massive bilateral pheocromocitomas: a rare case

Martins D , Baptista C , Rodrigues D , Miguel Melo , Cardoso L M , Vicente N , Oliveira D , Ventura M , Lages A , Carrilho F

Introduction: Pheochromocytoma is a rare catecholamine-secreting tumor that arises from the chromaffin tissue of the adrenal medulla. Of the reported cases, only 10% consist in bilateral lesions and the probability of multiple endocrine neoplasia should always be investigated.Clinical case: Female patient, 19 years old, presented with a clinical history with 2 years of evolution, characterized by episodes of palpitations, headache, nausea and abdominal d...

ea0070aep457 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Real-life clinical experience with GLP1 analogs and SGLT2 inhibitors in the treatment of diabetes type 2 and obesity

Pérez-Rodríguez José , Calderón-Vicente Dulce , González-López Javier , Martín-Iglesias David , Alramadan Mubarak

Objectives: SGLT2 inhibitors and GLP1 analogs are the treatment of choice after metformin in patients with type 2 diabetes (DM2) and overweight-obesity (OB). The aim of this study is to analyze the effectiveness and safety of these treatments alone or in combination.Methodology: This is a retrospective observational study in the usual clinical practice. We analyzed the effects of SGLT2 inhibitors and GLP1 analogs treatments in patients with DM2 and OB wh...